Matches in SemOpenAlex for { <https://semopenalex.org/work/W3184167413> ?p ?o ?g. }
- W3184167413 endingPage "2589" @default.
- W3184167413 startingPage "2576" @default.
- W3184167413 abstract "Background: Nonalcoholic steatohepatitis (NASH) is the most severe form of non-alcoholic fatty liver disease (NAFLD) and a potential precursor of hepatocellular carcinoma (HCC). In our previous studies, we found that endocrine fibroblast growth factor 21 (FGF21) played a key role in preventing the development of NASH, however, the FGF15/19 mediated-FGFR4 signaling worsened NASH and even contributed to the NASH-HCC transition. The aim of this study is to determine whether FGF15/FGFR4 signaling could alleviate or aggravate NASH in the FGF21KO mice. Methods: NASH models were established in FGF21KO mice fed with high fat methionine-choline deficient (HFMCD) diet to investigate FGF15/FGFR4 signaling during early stage NASH and advanced stage NASH. Human hepatocytes, HepG2 and Hep3B cells, were cultured with human enterocytes Caco-2 cells to mimic gut-liver circulation to investigate the potential mechanism of NASH development. Results: Significant increase of FGF15 production was found in the liver of the NASH-FGF21KO mice, however the increased FGF15 protein was unable to alleviate hepatic lipid accumulation. In contrast, up-regulated FGF15/19/FGFR4 signaling was found in the FGF21KO mice with increased NASH severity, as evident by hepatocyte injury/repair, fibrosis and potential malignant events. In in vitro studies, blockage of FGFR4 by BLU9931 treatment attenuated the lipid accumulation, up-regulated cyclin D1, and epithelial-mesenchymal transition (EMT) in the hepatocytes. Conclusion: The increased FGF15 in NASH-FGF21KO mice could not substitute for FGF21 to compensate its lipid metabolic benefits thereby to prevent NASH development. Up-regulated FGFR4 signaling in NASH-FGF21KO mice coupled to proliferation and EMT events which were widely accepted to be associated with carcinogenic transformation." @default.
- W3184167413 created "2021-08-02" @default.
- W3184167413 creator A5010870618 @default.
- W3184167413 creator A5024708104 @default.
- W3184167413 creator A5029877054 @default.
- W3184167413 creator A5036574100 @default.
- W3184167413 creator A5040180700 @default.
- W3184167413 creator A5043764158 @default.
- W3184167413 creator A5046269376 @default.
- W3184167413 creator A5069026924 @default.
- W3184167413 creator A5075808008 @default.
- W3184167413 creator A5080666814 @default.
- W3184167413 date "2021-01-01" @default.
- W3184167413 modified "2023-10-17" @default.
- W3184167413 title "Aberrant FGFR4 signaling worsens nonalcoholic steatohepatitis in FGF21KO mice" @default.
- W3184167413 cites W1881423069 @default.
- W3184167413 cites W1968091833 @default.
- W3184167413 cites W2010769778 @default.
- W3184167413 cites W2011307032 @default.
- W3184167413 cites W2027239974 @default.
- W3184167413 cites W2031236987 @default.
- W3184167413 cites W2041451676 @default.
- W3184167413 cites W2042055907 @default.
- W3184167413 cites W2045653945 @default.
- W3184167413 cites W2050259739 @default.
- W3184167413 cites W2062842771 @default.
- W3184167413 cites W2071424677 @default.
- W3184167413 cites W2077079473 @default.
- W3184167413 cites W2095244962 @default.
- W3184167413 cites W2095866442 @default.
- W3184167413 cites W2099552482 @default.
- W3184167413 cites W2105359426 @default.
- W3184167413 cites W2106986971 @default.
- W3184167413 cites W2119331212 @default.
- W3184167413 cites W2121423336 @default.
- W3184167413 cites W2128911132 @default.
- W3184167413 cites W2130787560 @default.
- W3184167413 cites W2132596222 @default.
- W3184167413 cites W2134944069 @default.
- W3184167413 cites W2147189332 @default.
- W3184167413 cites W2168535299 @default.
- W3184167413 cites W2289285922 @default.
- W3184167413 cites W2473806208 @default.
- W3184167413 cites W2528192178 @default.
- W3184167413 cites W2560175003 @default.
- W3184167413 cites W2581434358 @default.
- W3184167413 cites W2731063128 @default.
- W3184167413 cites W2735805490 @default.
- W3184167413 cites W2759832097 @default.
- W3184167413 cites W2765324118 @default.
- W3184167413 cites W2765568139 @default.
- W3184167413 cites W2767116475 @default.
- W3184167413 cites W2789543207 @default.
- W3184167413 cites W2793275191 @default.
- W3184167413 cites W2805121591 @default.
- W3184167413 cites W2810518407 @default.
- W3184167413 cites W2895607249 @default.
- W3184167413 cites W2898462029 @default.
- W3184167413 cites W2904469476 @default.
- W3184167413 cites W2948685669 @default.
- W3184167413 cites W3003796365 @default.
- W3184167413 cites W3005051813 @default.
- W3184167413 cites W3008387082 @default.
- W3184167413 cites W32883903 @default.
- W3184167413 cites W899071949 @default.
- W3184167413 cites W90736706 @default.
- W3184167413 doi "https://doi.org/10.7150/ijbs.58776" @default.
- W3184167413 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8315028" @default.
- W3184167413 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34326695" @default.
- W3184167413 hasPublicationYear "2021" @default.
- W3184167413 type Work @default.
- W3184167413 sameAs 3184167413 @default.
- W3184167413 citedByCount "5" @default.
- W3184167413 countsByYear W31841674132022 @default.
- W3184167413 countsByYear W31841674132023 @default.
- W3184167413 crossrefType "journal-article" @default.
- W3184167413 hasAuthorship W3184167413A5010870618 @default.
- W3184167413 hasAuthorship W3184167413A5024708104 @default.
- W3184167413 hasAuthorship W3184167413A5029877054 @default.
- W3184167413 hasAuthorship W3184167413A5036574100 @default.
- W3184167413 hasAuthorship W3184167413A5040180700 @default.
- W3184167413 hasAuthorship W3184167413A5043764158 @default.
- W3184167413 hasAuthorship W3184167413A5046269376 @default.
- W3184167413 hasAuthorship W3184167413A5069026924 @default.
- W3184167413 hasAuthorship W3184167413A5075808008 @default.
- W3184167413 hasAuthorship W3184167413A5080666814 @default.
- W3184167413 hasBestOaLocation W31841674131 @default.
- W3184167413 hasConcept C106646824 @default.
- W3184167413 hasConcept C126322002 @default.
- W3184167413 hasConcept C134018914 @default.
- W3184167413 hasConcept C170493617 @default.
- W3184167413 hasConcept C2775936931 @default.
- W3184167413 hasConcept C2778019345 @default.
- W3184167413 hasConcept C2778772119 @default.
- W3184167413 hasConcept C2779134260 @default.
- W3184167413 hasConcept C2779478299 @default.
- W3184167413 hasConcept C502942594 @default.
- W3184167413 hasConcept C55493867 @default.